Brookfield Infrastructure Partners Exchange L.P. (“BIP Exchange LP”), a subsidiary of Brookfield Infrastructure Partners L.P. (“BIP”), today announced that, in connection with the announcement by
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Brookfield Infr Partners (NYSE:BIP) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement.
Analysts estimate that Brookfield Infr Partners will report an earnings per share (EPS) of $0.13.
Companies Reporting Before The Bell
• R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion.
Brookfield Infrastructure Partners L.P. (NYSE:BIP, TSX:BIP), together with its institutional partners (collectively, "Brookfield Infrastructure") are pleased to announce that Brookfield Infrastructure has paid
Brookfield Infr Partners (NYSE:BIP) reported quarterly earnings of $0.85 per share. This is a 18.06 percent increase over earnings of $0.72 per share from the same period last year.